CVS Health announced in Woonsocket, Rhode Island, on November 4 that it plans to split into two listed companies, separating retail pharmacies from insurance and pharmacy-benefit operations. Reuters reported that shares closed down 12.5% at $79.96, erasing nearly $15 billion in market value.
The move reverses part of an expansion built through acquisitions, including the roughly $78 billion purchase of Aetna in 2018, according to Reuters. The news agency reported growing criticism that combining different healthcare businesses can create conflicts of interest and increase costs.
According to CVS, the healthcare solutions company will retain Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health. It will initially keep the CVS Health name. Current chairman and chief executive David Joyner will lead that company in both roles.
CVS Pharmacy will comprise about 9,000 stores, mail pharmacy, MinuteClinic, including virtual care, and technology services business Health100, the company said. Group president Prem Shah will become its chief executive. CVS said the structure should give each business more strategic focus and flexibility over capital allocation.
Reuters reported that Barclays analyst Andrew Mok identified limited financial detail about the breakup as a key investor concern. CVS said customers would continue receiving medicines, care and benefits without interruption. Those assurances describe the company's plans rather than a completed change in services or ownership.
CVS expects completion in the first half of 2028, with shareholders receiving stakes in both businesses. Its SEC filing says the transaction still requires final board approval, an effective registration statement and confirmation of the intended tax-free treatment. The filing warns that execution could disrupt operations and that neither the timetable nor the expected benefits are guaranteed.
Comments